The Discounted Cash Flow (DCF) valuation of Nuvation Bio Inc (NUVB) is (48.43) USD. With the latest stock price at 2.13 USD, the upside of Nuvation Bio Inc based on DCF is -2373.9%.
Based on the latest price of 2.13 USD and our DCF valuation, Nuvation Bio Inc (NUVB) is a sell. selling NUVB stocks now will result in a potential gain of 2373.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 7.9% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (119.85) - (31.14) | (48.43) |
| Upside | -5726.6% - -1562.2% | -2373.9% |